Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIM Study
NCT05361499Completed
- Sponsor
- Radboud University Medical Center
- Start
- May 2022
- Primary completion
- Feb 2023
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Radboud University Medical Center. Primary endpoint: Percentage of volunteers infected with S. pneumoniae serotype 6B following inoculation at 4 weeks. Started May 2022; status: completed.
Beyond the preview
Go deeper on NCT05361499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05361499.